China National Accord Medicines Corporation Ltd. (SHE:000028)

SHE:000028 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,542	7,409	6,502	6,016	5,126	5,998
Short-Term Investments	-	-	-	-	-	287.13
Cash & Short-Term Investments	5,542	7,409	6,502	6,016	5,126	6,285
Cash Growth	-3.17%	13.94%	8.08%	17.37%	-18.44%	-31.39%
Accounts Receivable	25,102	21,118	20,235	16,202	17,701	15,842
Other Receivables	732.38	146.41	265.56	66.85	87.26	178.77
Receivables	25,834	21,298	20,539	16,306	17,855	16,067
Inventory	8,021	7,406	7,989	7,836	7,622	6,285
Other Current Assets	742.31	1,464	1,340	1,550	1,246	624.39
Total Current Assets	40,140	37,576	36,370	31,708	31,848	29,262
Property, Plant & Equipment	3,334	3,479	3,724	3,407	3,494	3,258
Long-Term Investments	3,176	3,080	2,947	2,799	2,658	2,507
Goodwill	1,859	1,859	2,747	2,750	2,776	2,747
Other Intangible Assets	468.05	479.54	615.59	647.52	669.93	734.35
Long-Term Accounts Receivable	-	12.93	15.91	13.68	16.59	7
Long-Term Deferred Tax Assets	256.65	249.41	220.48	185.25	129.74	92.12
Long-Term Deferred Charges	430.02	467.67	526.58	572.55	633.98	457.71
Other Long-Term Assets	359.4	352.1	404.42	532.4	557.38	528.64
Total Assets	50,023	47,556	47,571	42,616	42,784	39,595
Accounts Payable	19,607	18,100	17,952	15,233	16,718	15,218
Accrued Expenses	240.43	779.14	760.58	998.17	753.2	812.86
Short-Term Debt	3,731	3,422	2,903	2,133	2,490	2,200
Current Portion of Long-Term Debt	-	-	17	45.14	-	-
Current Portion of Leases	966.98	944.37	1,002	867.85	848.33	748.73
Current Income Taxes Payable	302.57	128.03	205.9	237.8	178.87	173.02
Current Unearned Revenue	314.85	349.74	456.3	586.96	450.59	380.95
Other Current Liabilities	1,875	1,079	1,041	926.05	939.8	724.62
Total Current Liabilities	27,038	24,802	24,338	21,028	22,379	20,258
Long-Term Debt	-	-	-	17.5	71.64	31.64
Long-Term Leases	1,272	1,371	1,452	1,327	1,375	1,303
Long-Term Unearned Revenue	67.52	69.48	74.97	80.91	87.72	90.64
Long-Term Deferred Tax Liabilities	111.7	114.5	146.05	156.48	175.95	205.92
Other Long-Term Liabilities	431.33	441.99	581.45	560.3	670.52	815.81
Total Liabilities	28,921	26,800	26,593	23,171	24,761	22,706
Common Stock	556.57	556.57	556.57	428.13	428.13	428.13
Additional Paid-In Capital	4,261	4,261	4,261	4,357	4,372	4,373
Retained Earnings	13,182	12,854	12,590	11,333	10,103	9,109
Comprehensive Income & Other	-1.45	-1.45	7.87	7.91	21.87	38.48
Total Common Equity	17,998	17,670	17,415	16,126	14,925	13,948
Minority Interest	3,104	3,086	3,563	3,319	3,097	2,940
Shareholders' Equity	21,102	20,755	20,978	19,445	18,022	16,889
Total Liabilities & Equity	50,023	47,556	47,571	42,616	42,784	39,595
Total Debt	5,971	5,737	5,374	4,391	4,786	4,283
Net Cash (Debt)	-428.73	1,671	1,129	1,626	340.48	2,002
Net Cash Growth	-	48.07%	-30.58%	377.51%	-82.99%	-60.14%
Net Cash Per Share	-0.77	3.00	2.03	2.92	0.61	3.60
Filing Date Shares Outstanding	556.57	556.57	556.57	556.57	556.57	556.57
Total Common Shares Outstanding	556.57	556.57	556.57	556.57	556.57	556.57
Working Capital	13,102	12,774	12,032	10,681	9,469	9,005
Book Value Per Share	32.34	31.75	31.29	28.97	26.82	25.06
Tangible Book Value	15,671	15,331	14,053	12,728	11,479	10,467
Tangible Book Value Per Share	28.16	27.55	25.25	22.87	20.63	18.81
Buildings	-	807.91	741.11	738.01	725.86	704.64
Machinery	-	1,396	1,294	1,132	1,027	888.91
Construction In Progress	-	12.6	35.44	35.17	49.85	46.63

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.